With its strategic initiative to facilitate the merger of Meona and i-SOLUTIONS, Trill Impact underscores its strong expertise in supporting mid-cap businesses. Merger clearance has been obtained and both transactions have now been completed.
By combining the two companies, Trill Impact enables Meona and i-SOLUTIONS to offer their customers an unparalleled, one-stop-shop solution for clinical and administrative medical software. As a leading player in its field, the Group will be well positioned to generate significant growth, leveraging the complementary strengths of the two businesses. Meona will contribute its market-leading clinical software that supports the work processes and requirements of modern clinical practices. Its products include specialized solutions for medication and data management not only for the emergency room, but also for other critical medical workflows in normal and intensive care wards. Meona’s solutions focus on improving the efficiency in medical digital infrastructure of mid- to large-sized hospitals (including university clinics) in continental Europe, while i-SOLUTIONS, reputed for its holistic approach, will provide its specialized, highly reliable and customized software (including workflow and patient management software solutions) for hospitals, radiology practices and laboratories.
The combined Group’s offering will help modernize a digitally underserved healthcare system in continental Europe, improve patient safety and quality of care, and contribute to a resilient and resource-efficient healthcare infrastructure for the digital future. The Group intends to use its strong market position to support the digitalization efforts of its customers as well as the ambitions of all other stakeholders. The importance of the digitalization of healthcare providers is widely acknowledged and supported by several public initiatives. The Group is also open to partner with others who share its vision to drive innovation in digital healthcare.
Kristian Klosterkemper, Director at Trill Impact, looks forward to supporting Meona and i-SOLUTIONS in their joint ambition:
“The products of both companies address pressing societal challenges to improve patient safety, quality of care and care efficiency. At the same time, we believe that these products have great growth potential in a highly attractive market environment. This is an example where Trill Impact actively sought and created opportunities. In this particular case, we initiated discussions more than nine months ago and we are proud to have succeeded in such an ambitious transaction situation.”
Dr. Tobias Schäfer, medical doctor and CEO of the Group, adds:
“With Trill Impact, we have found an owner who shares our vision and entrepreneurial spirit. Looking ahead, we want to combine our strength in innovation with the experience and product range of i-SOLUTIONS. This will help make us the market-leading software provider in the healthcare sector. We are confident that our customers will benefit enormously from this partnership."
For Trill Impact, these two acquisitions are the first transactions in the DACH region. Korbinian Knoblach, who leads the DACH Trill Impact advisory team, is excited about the many opportunities he sees in this region:
“As a private equity firm which supports mid-sized companies in Northern Europe that address social and environmental challenges in line with the UN Sustainable Development Goals, it is gratifying to see how much interest Trill Impact receives from entrepreneurs and managers who want to join forces with us to address these challenges, while at the same time striving for innovation and leading positions in their markets.”
